AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Cemat

Director's Dealing Sep 9, 2025

3426_rpt_2025-09-09_d619b7e0-c317-4ed5-906f-ce7750af4827.html

Director's Dealing

Open in Viewer

Opens in native device viewer

No. 18/2025 - Managers’ transactions

No. 18/2025 - Managers’ transactions

Nasdaq Copenhagen                                                                                   

Nikolaj Plads 6

DK-1067 Copenhagen K   

Copenhagen, 9 September 2025

ANNOUNCEMENT no. 18/2025

Managers’ transactions

Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 8 September 2025.

Details of the person discharging managerial responsibilities/person closely associated
Name: Frede Clausen
Reason for the notification:
Position/status: Chairman of the board of directors in Cemat A/S
Initial notification/Amendment: Initial
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name: Cemat A/S
LEI: 213800899MWAZT9KQZ78
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument: Shares
Identification code: ISIN DK0010271584
Nature of the transaction: Purchase of shares
Price(s): DKK 845,158.17
Volume (s): 811,248
Aggregated information:
- Aggregated volume 811,248
- Price DKK 845,158.17, equivalent to DKK 1.0418 per share
Date of the transaction: 5 September 2025
Place of the transaction: Nasdaq Copenhagen, XCSE

Cemat A/S

Jaroslaw Pawel Lipinski

CEO                      

This announcement has been prepared in a Danish-language and an English-language

version. In case of doubt, the Danish version prevails.

Attachment

Talk to a Data Expert

Have a question? We'll get back to you promptly.